IRCT201506201556N77
Completed
Phase 2
Duloxetine as adjunctive treatment of negative symptoms in patients with schizophrenia: a double blind and placebo controlled trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- schizophrenia.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 50
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\-Diagnosis of Schizophrenia based on DSM\-5 criteria; 2\- Age between 18\-60; 3\-Chronic Schizophrenia\- duration of the disorder more than 2 years; 4\-Minimum score of 20 in negative sub score. 5\-being stable on risperidone for the last 2 months Exclusion criteria:1\-Any serious medical or neurological problem; 2\- IQ less than 70; 3\- Substance dependence during the last 6 months(except for nicotine and caffeine); 4\- Score on HDRS less than 14 5\-receiving ECT during the last 3 months ; 6\-Acute or chronic systemic diseases; 7\- History of neurosurgery; 8\- History of head trauma
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effect of Deluxitine on the negative symptoms of schizophreniaIRCT20191218045795N2Sanandaj University of Medical Sciences44
Recruiting
Phase 2
Vortioxetine as adjunctive treatment of schizophreniaSchizophrenia.SchizophreniaIRCT201710241556N100Tehran University of Medical Sciences50
Completed
Not Applicable
Doluxetine add on conventional treatment in in?ammatory bowel disease patientsCondition 1: In?ammatory bowel disease. Condition 2: In?ammatory bowel disease.Crohn disease [regional enteritis]Ulcerative colitisIRCT201411127841N8Isfahan University of Medical Sciences, Psychosomatic Research Center40
Completed
Not Applicable
Duloxetine plus collaborative care treatment versus Duloxetine alone in the treatment of concomitant pain and depressive disorder. A randomized clinical trial in primary care.pijnklachtenDepressionMajor Depressive Dissorder10027946NL-OMON31476Trimbos instituut116
Completed
Not Applicable
Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with RitaliIRCT201110127462N2Tehran University of Medical Sciences40